Global Somatostatin Market Insights, Forecast to 2025
- QYR2791224
- 129 Pages
- October 2018
- Pharmaceuticals
This research report categorizes the global Somatostatin market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.
Somatostatin is one kind of hormone. It is widely distributed throughout the body, especially in the hypothalamus and pancreas. It also acts as an important regulator of endocrine and nervous system function by inhibiting the secretion of several other hormones such as growth hormone, insulin, and gastrin.
Somatostatin is one of the fastest growing medical Products in recent years in China. China is also the world's most rapid expansion Market. Rapid growth numbers of general hospital form a strong Market Demand of Somatostatin, especially the demand of second class and below second class hospital.
As the analogue is expanding in the market, and the price of Somatostatin not decreasing so much, Somatostatin will limited in many regions, like North America and EU. Even though the analogue and regional limited, the consumption of Somatostatin is keeping quick growth rate.
In 2017, the global Somatostatin market size was 210 million US$ and is forecast to 460 million US in 2025, growing at a CAGR of 11.4% from 2018. The objectives of this study are to define, segment, and project the size of the Somatostatin market based on company, product type, application and key regions.
The various contributors involved in the value chain of Somatostatin include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Somatostatin include
Merck (Schweiz) AG
SANOFI-AVENTIS FRANCE
Lyomark Pharma GmbH
ALFA WASSERMANN S.p.A.
Polypeptide Laboratories, Inc
SAMARTH
UBPL
HYBIO
TianTaiShan
Yangtze River
Siyao
Shuangcheng
Hainan Zhonghe
SL PHARM
Wuhan Hualong
Qingdao Guoda
Chengdu Shengnuo
Longjin
Market Size Split by Type
0.25
0.75
3
Market Size Split by Application
Application 1
Application 2
Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Somatostatin market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Somatostatin market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Somatostatin manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Somatostatin with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Somatostatin submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Somatostatin are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Somatostatin market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 Study Coverage
1.1 Somatostatin Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Somatostatin Market Size Growth Rate by Type
1.4.2 0.25
1.4.3 0.75
1.4.4 3
1.5 Market by Application
1.5.1 Global Somatostatin Market Size Growth Rate by Application
1.5.2 Application 1
1.5.3 Application 2
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Somatostatin Market Size
2.1.1 Global Somatostatin Revenue 2016-2025
2.1.2 Global Somatostatin Sales 2016-2025
2.2 Somatostatin Growth Rate by Regions
2.2.1 Global Somatostatin Sales by Regions
2.2.2 Global Somatostatin Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Somatostatin Sales by Manufacturers
3.1.1 Somatostatin Sales by Manufacturers
3.1.2 Somatostatin Sales Market Share by Manufacturers
3.1.3 Global Somatostatin Market Concentration Ratio (CR5 and HHI)
3.2 Somatostatin Revenue by Manufacturers
3.2.1 Somatostatin Revenue by Manufacturers (2016-2018)
3.2.2 Somatostatin Revenue Share by Manufacturers (2016-2018)
3.3 Somatostatin Price by Manufacturers
3.4 Somatostatin Manufacturing Base Distribution, Product Types
3.4.1 Somatostatin Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Somatostatin Product Category
3.4.3 Date of International Manufacturers Enter into Somatostatin Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Somatostatin Sales by Type
4.2 Global Somatostatin Revenue by Type
4.3 Somatostatin Price by Type
5 Breakdown Data by Application
5.1 Overview
5.2 Global Somatostatin Breakdown Data by Application
6 North America
6.1 North America Somatostatin by Countries
6.1.1 North America Somatostatin Sales by Countries
6.1.2 North America Somatostatin Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Somatostatin by Type
6.3 North America Somatostatin by Application
6.4 North America Somatostatin by Company
7 Europe
7.1 Europe Somatostatin by Countries
7.1.1 Europe Somatostatin Sales by Countries
7.1.2 Europe Somatostatin Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Somatostatin by Type
7.3 Europe Somatostatin by Application
7.4 Europe Somatostatin by Company
8 Asia Pacific
8.1 Asia Pacific Somatostatin by Countries
8.1.1 Asia Pacific Somatostatin Sales by Countries
8.1.2 Asia Pacific Somatostatin Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Somatostatin by Type
8.3 Asia Pacific Somatostatin by Application
8.4 Asia Pacific Somatostatin by Company
9 Central & South America
9.1 Central & South America Somatostatin by Countries
9.1.1 Central & South America Somatostatin Sales by Countries
9.1.2 Central & South America Somatostatin Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Somatostatin by Type
9.3 Central & South America Somatostatin by Application
9.4 Central & South America Somatostatin by Company
10 Middle East and Africa
10.1 Middle East and Africa Somatostatin by Countries
10.1.1 Middle East and Africa Somatostatin Sales by Countries
10.1.2 Middle East and Africa Somatostatin Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Somatostatin by Type
10.3 Middle East and Africa Somatostatin by Application
10.4 Middle East and Africa Somatostatin by Company
11 Company Profiles
11.1 Merck (Schweiz) AG
11.1.1 Merck (Schweiz) AG Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Somatostatin
11.1.4 Somatostatin Product Description
11.1.5 Recent Development
11.2 SANOFI-AVENTIS FRANCE
11.2.1 SANOFI-AVENTIS FRANCE Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Somatostatin
11.2.4 Somatostatin Product Description
11.2.5 Recent Development
11.3 Lyomark Pharma GmbH
11.3.1 Lyomark Pharma GmbH Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Somatostatin
11.3.4 Somatostatin Product Description
11.3.5 Recent Development
11.4 ALFA WASSERMANN S.p.A.
11.4.1 ALFA WASSERMANN S.p.A. Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Somatostatin
11.4.4 Somatostatin Product Description
11.4.5 Recent Development
11.5 Polypeptide Laboratories, Inc
11.5.1 Polypeptide Laboratories, Inc Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Somatostatin
11.5.4 Somatostatin Product Description
11.5.5 Recent Development
11.6 SAMARTH
11.6.1 SAMARTH Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Somatostatin
11.6.4 Somatostatin Product Description
11.6.5 Recent Development
11.7 UBPL
11.7.1 UBPL Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Somatostatin
11.7.4 Somatostatin Product Description
11.7.5 Recent Development
11.8 HYBIO
11.8.1 HYBIO Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Somatostatin
11.8.4 Somatostatin Product Description
11.8.5 Recent Development
11.9 TianTaiShan
11.9.1 TianTaiShan Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Somatostatin
11.9.4 Somatostatin Product Description
11.9.5 Recent Development
11.10 Yangtze River
11.10.1 Yangtze River Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of Somatostatin
11.10.4 Somatostatin Product Description
11.10.5 Recent Development
11.11 Siyao
11.12 Shuangcheng
11.13 Hainan Zhonghe
11.14 SL PHARM
11.15 Wuhan Hualong
11.16 Qingdao Guoda
11.17 Chengdu Shengnuo
11.18 Longjin
12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators
13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Somatostatin Raw Material
13.1.2 Somatostatin Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
Figure Picture of Somatostatin
Figure Global Somatostatin Production (K Pcs) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Somatostatin Production Market Share by Types (Product Category) in 2017
Figure 0.25 Product Picture
Table Major Manufacturers of 0.25
Figure 0.75 Product Picture
Table Major Manufacturers of 0.75
Figure 3 Product Picture
Table Major Manufacturers of 3
Table Global Somatostatin Market Size Growth Rate by Application 2018-2025 (K Pcs)
Figure Application 1
Figure Application 2
Figure Somatostatin Report Years Considered
Figure Global Somatostatin Market Size 2016-2025 (Million US$)
Figure Global Somatostatin Sales 2016-2025 (K Pcs)
Table Global Somatostatin Market Size by Regions 2016-2025 (K Pcs) & (Million US$)
Table Global Somatostatin Sales by Regions 2016-2025 (K Pcs)
Table Global Somatostatin Sales Market Share by Regions 2016-2025
Figure Global Somatostatin Sales Market Share by Regions 2016-2025
Figure 2017 Global Somatostatin Sales Market Share by Regions
Table Global Somatostatin Revenue by Regions 2016-2025 (Million US$)
Table Global Somatostatin Revenue Market Share by Regions 2016-2025
Figure Global Somatostatin Revenue Market Share by Regions 2016-2025
Figure 2017 Global Somatostatin Revenue Market Share by Regions
Table Global Somatostatin Sales by Manufacturers (2016-2018) (K Pcs)
Table Global Somatostatin Sales Share by Manufacturers (2016-2018)
Figure Global Somatostatin Sales Share by Manufacturers in 2017
Table Somatostatin Revenue by Manufacturers (2016-2018) (Million US$)
Table Somatostatin Revenue Share by Manufacturers (2016-2018)
Figure Somatostatin Value Share by Manufacturers in 2017
Table Global Somatostatin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Somatostatin Price (2016-2018) (USD/Pcs)
Table Somatostatin Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Somatostatin Product Category
Table Date of International Manufacturers Enter into Somatostatin Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Somatostatin Sales by Type (2016-2025) (K Pcs)
Table Global Somatostatin Sales Share by Type (2016-2025)
Figure Global Somatostatin Sales Market Share by Type (2016-2025)
Figure Global Somatostatin Sales Market Share by Type in 2017
Table Global Somatostatin Revenue by Type (2016-2025) (Million US$)
Table Global Somatostatin Revenue Share by Type (2016-2025)
Figure Global Somatostatin Revenue Market Share by Type (2016-2025)
Figure Global Somatostatin Revenue Market Share by Type in 2017
Table Somatostatin Price by Type 2013-2018 (USD/Pcs)
Table Global Somatostatin Sales by Application (2016-2025) (K Pcs)
Table Global Somatostatin Sales Share by Application (2016-2025)
Figure Global Sales Somatostatin Market Share by Application (2016-2025)
Figure Global Sales Somatostatin Market Share by Application (2016-2025)
Figure North America Somatostatin Sales Growth Rate 2016-2025 (K Pcs)
Figure North America Somatostatin Revenue Growth Rate 2016-2025 (Million US$)
Table North America Somatostatin Sales by Countries (2016-2025) (K Pcs)
Table North America Somatostatin Sales Market Share by Countries (2016-2025)
Figure 2017 North America Somatostatin Sales Market Share by Countries
Table North America Somatostatin Revenue by Countries (2016-2025) (Million US$)
Table North America Somatostatin Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Somatostatin Revenue Market Share by Countries
Figure United States Somatostatin Sales Growth Rate (2016-2025) (K Pcs)
Figure United States Somatostatin Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Somatostatin Sales Growth Rate (2016-2025) (K Pcs)
Figure Canada Somatostatin Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Somatostatin Sales Growth Rate (2016-2025) (K Pcs)
Figure Mexico Somatostatin Revenue Growth Rate (2016-2025) (Million US$)
Table North America Somatostatin Sales by Type (2016-2025) (K Pcs)
Table North America Somatostatin Sales Market Share by Type (2016-2025)
Figure 2017 North America Somatostatin Market Share by Type
Table North America Somatostatin Sales by Application (2016-2025) (K Pcs)
Table North America Somatostatin Sales Market Share by Application (2016-2025)
Figure 2017 North America Somatostatin Market Share by Application
Table North America Somatostatin Sales by Company (2016-2018) (K Pcs)
Table North America Somatostatin Sales Market Share by Company (2016-2018)
Figure North America Somatostatin Sales Market Share by Company in 2017
Figure Europe Somatostatin Sales Growth Rate 2016-2025 (K Pcs)
Figure Europe Somatostatin Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Somatostatin Sales by Countries (2016-2025) (K Pcs)
Table Europe Somatostatin Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Somatostatin Sales Market Share by Countries
Table Europe Somatostatin Revenue by Countries (2016-2025) (Million US$)
Table Europe Somatostatin Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Somatostatin Revenue Market Share by Countries
Figure Germany Somatostatin Sales Growth Rate (2016-2025) (K Pcs)
Figure Germany Somatostatin Revenue Growth Rate (2016-2025) (K Pcs)
Figure France Somatostatin Sales Growth Rate (2016-2025) (K Pcs)
Figure France Somatostatin Revenue Growth Rate (2016-2025) (K Pcs)
Figure UK Somatostatin Sales Growth Rate (2016-2025) (K Pcs)
Figure UK Somatostatin Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Somatostatin Sales Growth Rate (2016-2025) (K Pcs)
Figure Italy Somatostatin Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Somatostatin Sales Growth Rate (2016-2025) (K Pcs)
Figure Russia Somatostatin Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Somatostatin Sales by Type (2016-2025) (K Pcs)
Table Europe Somatostatin Sales Market Share by Type (2016-2025)
Figure 2017 Europe Somatostatin Market Share by Type
Table Europe Somatostatin Sales by Application (2016-2025) (K Pcs)
Table Europe Somatostatin Sales Market Share by Application (2016-2025)
Figure 2017 Europe Somatostatin Market Share by Application
Table Europe Somatostatin Sales by Company (2016-2018) (K Pcs)
Table Europe Somatostatin Sales Market Share by Company (2016-2018)
Figure Europe Somatostatin Sales Market Share by Company in 2017
Figure Asia Pacific Somatostatin Sales Growth Rate 2016-2025 (K Pcs)
Figure Asia Pacific Somatostatin Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Somatostatin Sales by Countries (2016-2025) (K Pcs)
Table Asia Pacific Somatostatin Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Somatostatin Sales Market Share by Countries
Table Asia Pacific Somatostatin Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Somatostatin Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Somatostatin Revenue Market Share by Countries
Figure China Somatostatin Sales Growth Rate (2016-2025) (K Pcs)
Figure China Somatostatin Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Somatostatin Sales Growth Rate (2016-2025) (K Pcs)
Figure Japan Somatostatin Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Somatostatin Sales Growth Rate (2016-2025) (K Pcs)
Figure Korea Somatostatin Revenue Growth Rate (2016-2025) (Million US$)
Figure India Somatostatin Sales Growth Rate (2016-2025) (K Pcs)
Figure India Somatostatin Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Somatostatin Sales Growth Rate (2016-2025) (K Pcs)
Figure Australia Somatostatin Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Somatostatin Sales Growth Rate (2016-2025) (K Pcs)
Figure Indonesia Somatostatin Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Somatostatin Sales Growth Rate (2016-2025) (K Pcs)
Figure Malaysia Somatostatin Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Somatostatin Sales Growth Rate (2016-2025) (K Pcs)
Figure Philippines Somatostatin Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Somatostatin Sales Growth Rate (2016-2025) (K Pcs)
Figure Thailand Somatostatin Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Somatostatin Sales Growth Rate (2016-2025) (K Pcs)
Figure Vietnam Somatostatin Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Somatostatin Sales Growth Rate (2016-2025) (K Pcs)
Figure Singapore Somatostatin Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Somatostatin Sales by Type (2016-2025) (K Pcs)
Table Asia Pacific Somatostatin Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Somatostatin Market Share by Type
Table Asia Pacific Somatostatin Sales by Application (2016-2025) (K Pcs)
Table Asia Pacific Somatostatin Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Somatostatin Market Share by Application
Table Asia Pacific Somatostatin Sales by Company (2016-2018) (K Pcs)
Table Asia Pacific Somatostatin Sales Market Share by Company (2016-2018)
Figure Asia Pacific Somatostatin Sales Market Share by Company in 2017
Figure Central & South America Somatostatin Sales Growth Rate 2016-2025 (K Pcs)
Figure Central & South America Somatostatin Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Somatostatin Sales by Countries (2016-2025) (K Pcs)
Table Central & South America Somatostatin Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Somatostatin Sales Market Share by Countries
Table Central & South America Somatostatin Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Somatostatin Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Somatostatin Revenue Market Share by Countries
Figure Brazil Somatostatin Sales Growth Rate (2016-2025) (K Pcs)
Figure Brazil Somatostatin Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Somatostatin Sales Growth Rate (2016-2025) (K Pcs)
Figure Argentina Somatostatin Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Somatostatin Sales by Type (2016-2025) (K Pcs)
Table Central & South America Somatostatin Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Somatostatin Market Share by Type
Table Central & South America Somatostatin Sales by Application (2016-2025) (K Pcs)
Table Central & South America Somatostatin Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Somatostatin Market Share by Application
Table Central & South America Somatostatin Sales by Company (2016-2018) (K Pcs)
Table Central & South America Somatostatin Sales Market Share by Company (2016-2018)
Figure Central & South America Somatostatin Sales Market Share by Company in 2017
Figure Middle East and Africa Somatostatin Sales Growth Rate 2016-2025 (K Pcs)
Figure Middle East and Africa Somatostatin Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Somatostatin Sales by Countries (2016-2025) (K Pcs)
Table Middle East and Africa Somatostatin Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Somatostatin Sales Market Share by Countries
Table Middle East and Africa Somatostatin Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Somatostatin Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Somatostatin Revenue Market Share by Countries
Figure GCC Countries Somatostatin Sales Growth Rate (2016-2025) (K Pcs)
Figure GCC Countries Somatostatin Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Somatostatin Sales Growth Rate (2016-2025) (K Pcs)
Figure Turkey Somatostatin Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Somatostatin Sales Growth Rate (2016-2025) (K Pcs)
Figure Egypt Somatostatin Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Somatostatin Sales Growth Rate (2016-2025) (K Pcs)
Figure South Africa Somatostatin Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Somatostatin Sales by Type (2016-2025) (K Pcs)
Table Middle East and Africa Somatostatin Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Somatostatin Market Share by Type
Table Middle East and Africa Somatostatin Sales by Application (2016-2025) (K Pcs)
Table Middle East and Africa Somatostatin Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Somatostatin Market Share by Application
Table Middle East and Africa Somatostatin Sales by Company (2016-2018) (K Pcs)
Table Middle East and Africa Somatostatin Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Somatostatin Sales Market Share by Company in 2017
Table Merck (Schweiz) AG Company Details
Table Merck (Schweiz) AG Somatostatin Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Merck (Schweiz) AG Recent Development
Table SANOFI-AVENTIS FRANCE Company Details
Table SANOFI-AVENTIS FRANCE Somatostatin Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table SANOFI-AVENTIS FRANCE Recent Development
Table Lyomark Pharma GmbH Company Details
Table Lyomark Pharma GmbH Somatostatin Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Lyomark Pharma GmbH Recent Development
Table ALFA WASSERMANN S.p.A. Company Details
Table ALFA WASSERMANN S.p.A. Somatostatin Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table ALFA WASSERMANN S.p.A. Recent Development
Table Polypeptide Laboratories, Inc Company Details
Table Polypeptide Laboratories, Inc Somatostatin Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Polypeptide Laboratories, Inc Recent Development
Table SAMARTH Company Details
Table SAMARTH Somatostatin Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table SAMARTH Recent Development
Table UBPL Company Details
Table UBPL Somatostatin Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table UBPL Recent Development
Table HYBIO Company Details
Table HYBIO Somatostatin Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table HYBIO Recent Development
Table TianTaiShan Company Details
Table TianTaiShan Somatostatin Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table TianTaiShan Recent Development
Table Yangtze River Company Details
Table Yangtze River Somatostatin Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Yangtze River Recent Development
Table Siyao Company Details
Table Shuangcheng Company Details
Table Hainan Zhonghe Company Details
Table SL PHARM Company Details
Table Wuhan Hualong Company Details
Table Qingdao Guoda Company Details
Table Chengdu Shengnuo Company Details
Table Longjin Company Details
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Somatostatin Value Chain
Table Typical Suppliers of Key Somatostatin Raw Material
Table Somatostatin Customers List
Table Somatostatin Sales Channels
Table Somatostatin Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
